Deutsche Bank reiterated coverage of Xilinx with a rating of Hold and set a new price target of $190.00 from $207.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/28/2022 | $210.00 → $175.00 | Neutral | Rosenblatt |
| 1/27/2022 | $210.00 → $190.00 | Neutral | JP Morgan |
| 1/27/2022 | $210.00 → $190.00 | Market Perform | Cowen |
| 1/27/2022 | $207.00 → $190.00 | Hold | Deutsche Bank |
| 12/15/2021 | $195.00 → $207.00 | Hold | Deutsche Bank |
| 10/28/2021 | $169.00 → $211.00 | Buy | Jefferies |
| 10/28/2021 | $150.00 → $200.00 | Neutral | Mizuho |
| 10/28/2021 | $155.00 → $195.00 | Hold | Deutsche Bank |
NEW YORK, Feb. 10, 2022 /PRNewswire/ -- S&P MidCap 400 constituent Nordson Corp. (NASD:NDSN) will replace Xilinx Inc. (NASD:XLNX) in the S&P 500, S&P SmallCap 600 constituent PDC Energy Inc. (NASD:PDCE) will replace Nordson in the S&P MidCap 400, and XPEL Inc. (NASD:XPEL) will replace PDC Energy in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, February 15. S&P 500 constituent Advanced Micro Devices (NASD: AMD) is acquiring Xilinx in a transaction expected to be completed on or about February 14. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker
NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced that AstraZeneca PLC – ADR (NASDAQ:AZN), will become a component of the NASDAQ-100 Index® (NASDAQ:NDX) and the NASDAQ-100 Equal Weighted Index (NASDAQ:NDXE) prior to market open on Tuesday, February 22, 2022. AstraZeneca PLC – ADR will replace Xilinx, Inc. (NASDAQ:XLNX) in the NASDAQ-100 Index® and the NASDAQ-100 Equal Weighted Index. For more information about the company, go to https://www.astrazeneca.com. About Nasdaq Nasdaq (NASDAQ:NDAQ) is a global technology company serving the capital markets and other industries. Our diverse offering of data, analytics, software and services enable
SILICON VALLEY, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- AMD (NASDAQ:AMD) today announced that it has received approval from all necessary authorities to proceed with the acquisition of Xilinx, Inc. (NASDAQ:XLNX). With the exception of the remaining customary closing conditions, all conditions to the transaction closing have been satisfied and the company expects the transaction to close on or about February 14, 2022. AMD announced its intention to acquire Xilinx in an all-stock transaction on October 27, 2020. The transaction brings together two industry leaders with complementary product portfolios and customers, combining CPUs, GPUs, FPGAs, Adaptive SoCs and deep software expertise t